Launch smarter. Price confidently. Win access. Build demand.
MAPP77 helps pharma teams turn complex assets into executable US commercialization plans spanning launch readiness, market access, pricing, and omnichannel execution—built with transparent assumptions and deliverables your team can actually run.
NDAs welcome. Conflicts disclosed up front.
Decision-ready GTM strategy and execution playbooks for US commercialization
Comprehensive readiness assessment, patient journey mapping, and launch governance frameworks.
Learn moreAccess landscape analysis, barrier mapping, and pull-through planning for competitive markets.
Learn morePricing corridor analysis, GTN assumptions, and price-volume tradeoff simulations.
Learn moreDriver-based forecasts, TAM/SAM/SOM sizing, and scenario planning with transparent assumptions.
Learn moreWe partner with teams navigating the complexities of US pharmaceutical commercialization, from early strategy through execution.
Teams needing positioning and channel plans that avoid commodity traps
Commercial stories tied to evidence, differentiation, and payer logic
Teams needing sharper strategy and execution realignment
Commercial diligence, market sizing, and risk-upside framing
"We're unsure who exactly will adopt and pay—help us define the real target segments."
"Pricing is debated internally—help us choose a defendable corridor and contracting strategy."
"Forecast numbers lack credibility—rebuild the logic and stress-test assumptions."
"Launch work is fragmented—create governance, a cadence, and clear ownership."
A structured approach that delivers clarity at every stage
Clarify the product truth, market reality, and constraints.
Build decision-ready options with tradeoffs (not a single guess).
Provide playbooks, models, and templates your team can execute.
Support execution with weekly cadences, dashboards, and enablement.
What makes us different from broad 'everything to everyone' GTM firms
Differentiated generics, complex products, and 505(b)(2) paths—not generalist consulting.
Price, contracting, and payer realities built into your plan from day one.
Models, playbooks, templates, and governance—not slide decks that sit on shelves.
2–6 week sprints or a fractional Launch Office—fit your timeline and budget.
Conflict-aware, NDA-ready, and transparent assumptions—no black boxes.
A comprehensive checklist covering the critical areas of US pharmaceutical launch preparation.
Let's discuss your commercialization challenges and how we can help.
Book a 30-min Call